Cargando…
COVID-19 and Cardiovascular Diseases: From Cellular Mechanisms to Clinical Manifestations
Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), quickly spread worldwide and led to over 581 million confirmed cases and over 6 million deaths as 1 August 2022. The binding of the viral surface spike protein to the human angiotensin-con...
Autores principales: | Shu, Hongyang, Wen, Zheng, Li, Na, Zhang, Zixuan, Ceesay, Bala Musa, Peng, Yizhong, Zhou, Ning, Wang, Dao Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676802/ https://www.ncbi.nlm.nih.gov/pubmed/37199573 http://dx.doi.org/10.14336/AD.2023.0314 |
Ejemplares similares
-
Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance
por: Shu, Hongyang, et al.
Publicado: (2023) -
Emerging Roles of Ceramide in Cardiovascular Diseases
por: Shu, Hongyang, et al.
Publicado: (2022) -
Emerging role of VCP/p97 in cardiovascular diseases: novel insights and therapeutic opportunities
por: Shu, Hongyang, et al.
Publicado: (2021) -
The role of CD36 in cardiovascular disease
por: Shu, Hongyang, et al.
Publicado: (2020) -
Trimetazidine in Heart Failure
por: Shu, Hongyang, et al.
Publicado: (2021)